Skip to main content
HCA
NYSE Life Sciences

HCA Plans Senior Notes Offering, Potentially $4 Billion, to Refinance Debt

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$434.699
Mkt Cap
$96.685B
52W Low
$321.39
52W High
$556.52
Market data snapshot near publication time

summarizeSummary

HCA Healthcare announced a proposed public offering of senior notes. The company indicated that the proceeds from this offering may be used to repay its $4 billion commercial paper program. This financing event, following the S-3ASR shelf registration filed earlier today, represents a material capital structure adjustment for the company. While it appears to be a refinancing of existing debt, the scale of the offering is significant. Traders will be watching for the final terms, size, and pricing of the notes, as well as the market's reception, to assess the impact on HCA's cost of capital and financial flexibility.

At the time of this announcement, HCA was trading at $434.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $96.7B. The 52-week trading range was $321.39 to $556.52. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed HCA - Latest Insights

HCA
Apr 27, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
7
HCA
Apr 24, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
HCA
Apr 24, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
HCA
Mar 13, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
8
HCA
Feb 10, 2026, 4:27 PM EST
Filing Type: 10-K
Importance Score:
9
HCA
Jan 27, 2026, 7:12 AM EST
Filing Type: 8-K
Importance Score:
9